TipRanks
Go Ultimate55% OFF

Polygiene AB (POLYG) AI Stock Analysis

SE:POLYG

Polygiene AB

(Nasdaq OMX AB:POLYG)

Select Model
Rating:41Neutral
Price Target:SEK 2.50â–²(6.84% Upside)
Action:reiterated
Date:10/28/26

Polygiene scores low primarily because of deteriorating fundamentals: shrinking revenue, a sharp gross margin compression from the mid-60% range to around 41%, and a swing back into net losses and negative free cash flow after a promising 2024. Technicals reinforce the caution, with the share price below all major moving averages and a negative MACD confirming an entrenched downtrend. Valuation adds no support given negative earnings and the absence of a dividend. The key mitigating factor is an exceptionally conservative balance sheet — virtually no debt, equity funding roughly 94% of assets, and a cash burn that is small in absolute terms — which buys management time to engineer a turnaround and provides meaningful upside leverage if volumes and margins recover. Until evidence of that stabilisation appears, the risk profile remains elevated.

Positive Factors
Low leverageA near-zero debt burden reduces refinancing and solvency risk while preserving financial flexibility. This conservative structure gives Polygiene more capacity to manage operating volatility and fund priorities without the added pressure of substantial interest obligations.
Negative Factors
Revenue contractionA declining revenue base signals weaker current demand or commercial execution and reduces the scale available to absorb operating costs. If the contraction persists, it can limit reinvestment capacity and make recovery in operating profitability more difficult over the next several quarters.

Polygiene AB (POLYG) vs. iShares MSCI Sweden ETF (EWD)

-80%-60%-40%-20%0%20%SE:POLYG-76.60%EWD+13.33%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
SEK 85.47M
Dividend Yield
―
Average Volume (3M)
51.98K
Price to Earnings (P/E)
-19.6
Beta (1Y)
0.23
Revenue Growth
-18.26%
EPS Growth
35.77%
Country
Sweden
Employees
34
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Polygiene AB Business Overview & Revenue Model

Company Description

Based in Malmö, Sweden, and founded in 2005, Polygiene Group AB develops, produces, and markets advanced solutions designed to control odors and maintain freshness across a wide range of materials. These applications extend to clothing, athletic equi...

Polygiene AB Financial Statement Overview

Summary

A split picture dominated by weak operations. Revenue has contracted from SEK 181.6m (2021) to SEK 146.6m (2025), with TTM of SEK 127.5m down a further 7.3%, while gross margin has collapsed from roughly 66% to about 41% on a TTM basis (Income Statement score 31). Cash generation has reversed sharply, with TTM operating cash flow of negative SEK 4.1m and free cash flow of negative SEK 5.2m after a solid 2024 (SEK 22.7m FCF), signalling an operational rather than investment-driven shortfall (Cash Flow score 29). The offset is a fortress balance sheet (score 78): total debt of just SEK 2.0m against SEK 287.2m of equity, which funds roughly 94% of assets, leaving the company effectively debt-free with ample room to absorb a small cash burn. However, equity has eroded from SEK 592.6m in 2022 following the 2023 impairment, and returns on equity remain negative.

Income Statement

31Negative

Balance Sheet

78Positive

Cash Flow

29Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue127.52M146.65M156.95M113.54M173.56M181.61M
Gross Profit48.04M48.32M103.78M77.16M114.57M115.24M
EBITDA-1.35M5.96M18.80M-304.02M20.34M43.99M
Net Income-4.29M-5.58M16.83M-321.95M8.36M32.83M
Balance Sheet
Total Assets307.06M304.74M350.84M313.78M621.90M550.69M
Cash, Cash Equivalents and Short-Term Investments34.20M38.78M68.59M44.15M48.06M52.40M
Total Debt2.02M4.57M2.63M3.89M1.64M2.40M
Total Liabilities19.91M28.56M31.23M22.53M29.34M31.54M
Stockholders Equity287.15M276.17M319.61M291.25M592.56M519.15M
Cash Flow
Free Cash Flow-5.62M-11.04M22.75M-4.27M-50.64M34.15M
Operating Cash Flow-4.13M-9.79M24.34M3.79M-1.54M37.60M
Investing Cash Flow-2.19M-4.07M-1.59M-9.42M-52.11M-407.47M
Financing Cash Flow-5.83M-9.67M-1.38M1.95M47.50M416.27M

Polygiene AB Technical Analysis

Technical Analysis SentimentNegative
Last Price2.34

Price Trends

50DMA3.49Negative
100DMA4.19Negative
200DMA5.55Negative

Market Momentum

MACD-0.32Positive
RSI31.98Neutral
STOCH11.29Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:POLYG, the sentiment is Negative. The current price of 2.34 is below the 20-day moving average (MA) of 3.04, below the 50-day MA of 3.49, and below the 200-day MA of 5.55, indicating a bearish trend. The MACD of -0.32 indicates Positive momentum. The RSI at 31.98 is Neutral, neither overbought nor oversold. The STOCH value of 11.29 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:POLYG.

Polygiene AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

SE:POLYG against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:HPOL.BSE:HPOL.B68NeutralSEK 31.74B17.5512.33%4.56%-0.82%-7.46%
SE:PCATSE:PCAT65NeutralSEK 14.87M4.56――-17.14%88.76%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
SE:SCA.ASE:SCA.A60NeutralSEK 84.54B39.092.14%2.50%-3.07%-38.98%
SE:ORGCSE:ORGC45NeutralSEK 83.91M-1.52-176.65%―-21.95%-28.77%
SE:NEXAMSE:NEXAM43NeutralSEK 258.28M-12.35-9.37%―-4.57%-15.20%
SE:POLYGSE:POLYG41NeutralSEK 85.47M-19.61-1.52%―-18.26%35.77%

* Basic Materials Sector Average

Performance Comparison

-50%0%50%SE:POLYGSE:HPOL.BSE:NEXAMSE:SCA.ASE:ORGCSE:PCATDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
SE:POLYG and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
SE:POLYGPolygiene AB2.34-7.06-75.11%
SE:HPOL.BHexpol AB92.1511.6114.42%
SE:NEXAMNexam Chemical Holding AB2.52-0.60-19.23%
SE:SCA.ASvenska Cellulosa Aktiebolaget Class A120.00-0.40-0.33%
SE:ORGCOrganoClick AB0.46-1.42-75.64%
SE:PCATPhotocat A/S2.48-2.32-48.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 28, 2026